Status:
WITHDRAWN
Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms
Lead Sponsor:
Takeda
Conditions:
Coronavirus Disease (COVID-19)
Eligibility:
All Genders
Brief Summary
This study is a survey of the Moderna COVID-19 vaccine in Japanese people at high risk of developing severe COVID-19 symptoms. The study sponsor will not be involved in how the participants are treate...
Eligibility Criteria
Inclusion
- The participant is capable of understanding the contents of the investigation, recording his/her own symptoms in the health observation diary, and has obtained written consent to participate in the investigation from the vaccinee himself/herself (If minor, parent or legal guardian).
- The participant has an underlying disease at the time of this drug vaccination that is considered to pose a high risk of aggravation of COVID-19.
Exclusion
- 1\. The subject has any contraindication to this drug.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04892888
Start Date
August 1 2022
End Date
April 30 2023
Last Update
July 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Takeda Selected Site
Tokyo, Japan